LETTER
Enantiospecific Synthesis of (+)-Calvine
489
column chromatography (SiO2, cyclohexane–EtOAc 3:2) to
give 2 (70 mg, 70%, as keto–enol mixture) as a brown oil.
[a]D20 –8.0 (c 1, CHCl3). 1H NMR (500 MHz, CDCl3): d =
0.81 (br s, 3 H, H-12), 1.20 (br s, 8 H, H-9–11), 1.45–1.59
(m, 2 H, H-8), 2.20–2.68 (m, 2 H, H-6), 3.29 (br s, 2 H, H-
13), 3.45 (s, H-2 keto), 3.50 (br s, 2 H, H-14), 3.68, 3.70 (s,
3 H, OCH3), 4.05 (br s, 1 H, H-7), 4.96 (s, H-2 enol), 5.12 (s,
2 H, H-16), 5.69–5.85 and 6.05–6.20 (m, 1 H, H-4), 6.45–
6.62 and 6.69–6.86 (m, 1 H, H-5), 7.21–7.41 (br s, 5 H, Ar),
11.75 (s, OH enol) ppm. 13C NMR (125 MHz, CDCl3): d =
14.0 (C-12), 22.6 (C-11), 26.1 (C-10), 31.6 (C-9), 33.1, 33.4
(C-8), 36.5, 37.0 (C-6), 46.4, 46.7 (C-13), 51.3 (C-7), 52.4
(OMe), 61.6, 62.6 (C-14), 67.2, 67.8 (C-15), 90.5 (C-2),
126.6 (C-4), 1276.9, 128.1, 128.3, 128.7, 131.3, 136.8 (Ar),
145.9, 147.0 (C-5), 155.6 (C-16), 173.3 (C-1), 191.7 (C-3)
ppm.
In summary, we have performed an enantioselective syn-
thesis of (+)-calvine in nine steps starting from (R)-epi-
chlorohydrine with an overall yield of 10%. The key
strategies included the copper-catalyzed oxirane opening,
SN2 reaction, and sequential CM–reductive cyclization
method. Further investigations and syntheses based on
this concept are currently under study in our laboratories
and the results will be reported in due course.
Acknowledgment
We are grateful to Daisho Ltd. Japan for their generous donation of
(R)-epichlorohydrine. P.D. thanks Prof. D. Daloze (Belgium) and
Dr. S. Maechling for valuable discussions.
(14) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett.
1999, 1, 953.
(15) Hattori, K.; Sajiki, H.; Hirota, K. Tetrahedron 2000, 56,
8433.
(16) Maki, S.; Okawa, M.; Makii, T.; Hirano, T.; Niwa, H.
Tetrahedron Lett. 2003, 44, 3717.
References and Notes
(1) Review on coccinellids: King, A. G.; Meinwald, J. Chem.
Rev. 1996, 96, 1105.
(2) (a) Laurent, P.; Braekman, J.-C.; Daloze, D. Eur. J. Org.
Chem. 2000, 2057. (b) Braekman, J.-C.; Chaelier, A.;
Daloze, D.; Heilporn, S.; Pasteels, J.; Plasman, V.; Wang, S.
Eur. J. Org. Chem. 1999, 1749.
(3) Review on CN(R,S) method: Husson, H.-P.; Royer, J. Chem.
Soc. Rev. 1999, 28, 393.
(4) (a) Gebauer, J.; Blechert, S. Synlett 2005, 2826.
(b) Gebauer, J.; Dewi, P.; Blechert, S. Tetrahedron Lett.
2005, 46, 43. (c) Randl, S.; Blechert, S. Tetrahedron Lett.
2004, 45, 1167.
(5) (a) Zibuck, R.; Streiber, J. Org. Synth. 1993, 71, 236.
(b) Zibuck, R.; Streiber, J. M. J. Org. Chem. 1989, 54, 4717.
(6) Jadhav, P. K.; Bhat, K. S.; Perumal, P. T.; Brown, H. C. J.
Org. Chem. 1986, 51, 432.
(7) (a) Costa, A. L.; Piazza, M. G.; Tagliavini, E.; Trombini, C.;
Umani-Ronchi, A. J. Am. Chem. Soc. 1993, 115, 7001. (b)
A similar method with a different titanium complex:
Hanawa, H.; Hashimoto, T.; Maruoka, K. J. Am. Chem. Soc.
2003, 125, 1708.
(17) Gómez-Monterrey, I.; González-Muñiz, R.; Herranz, R.;
Garcia-Gomez, T. Tetrahedron Lett. 1993, 34, 3593.
(18) Preparation and Selected Data of Piperidine 1.
Cross-metathesis product 2 (270 mg, 0.64 mmol) in
isopropyl ether (20 mL) was hydrogenated over 10% Pd/C
(68 mg, 60 mmol) at 3 bar and 40 °C for 3 d. After filtration
over Celite® and evaporation, the residue was purified by
column chromatography (SiO2, CH2Cl2–MeOH–NH3
97:3:0.1) to afford piperidine 1 (105 mg, 61%) and calvine
(20 mg, 13%) as a light-yellow oil. [a]D20 +8.5 (c 1.3,
CH2Cl2). 1H NMR (200 MHz, CDCl3): d = 0.88 (t, J = 7 Hz,
3 H, H-13), 1.10–1.80 (m, 14 H, H-3–5,9–12), 2.39 (dd,
J = 15, 9 Hz, 1 H, H-7), 2.51–2.77 (m, 4 H, H-6,7,14), 3.09–
3.25 (m, 1 H, H-2), 3.46 (t, J = 6 Hz, 2 H, H-15), 3.68 (s, 3
H, OCH3) ppm. 13C NMR (125 MHz, CDCl3): d = 14.1 (C-
13), 21.7 (C-4), 22.7 (C-12), 26.2 (C-3), 27.0 (C-10), 27.3
(C-5), 32.1 (C-11), 34.1 (C-9), 39.3 (C-7), 48.4 (C-14), 51.7
(OMe), 58.3 (C-2), 60.5 (C-15), 61.9 (C-6), 173.0 (C-8)
ppm.
(8) (a) Fürstner, A.; Thiel, O. R.; Kindler, N.; Bartkowska, B. J.
Org. Chem. 2000, 65, 7990. (b) Fürstner, A.; Konetzki, I. J.
Org. Chem. 1998, 63, 3072.
(19) Nilov, D.; Räcker, R.; Reiser, O. Synthesis 2002, 2232.
(20) Preparation and Selected Data of (+)-Calvine.
To a solution of 1 (12 mg, 44 mmol) in benzene (3 mL), p-
TSA monohydrate (9.2 mg, 48 mmol) was added and the
mixture was heated at reflux under a nitrogen atmosphere for
18 h. Then, CH2Cl2 (10 mL) and sat. aq NaHCO3 solution
(10 mL) were added and the layers were separated. The
aqueous layer was extracted with CH2Cl2 (3 × 10 mL), and
the collected organic layers were evaporated to give neat
calvine (7 mg, 66%) as a light-yellow oil. [a]D20 +18.3 (c
0.35, CH2Cl2) {lit.2 [a]D20 +18 (c 0.66, CH2Cl2)}. 1H NMR
(200 MHz, CDCl3): d = 0.88 (t, J = 7 Hz, 3 H, H-13), 1.15–
1.81 (m, 14 H, H-3–5,9–12), 2.19–2.89 (m, 5 H, H-6,7,14),
(9) Nakayama, Y.; Kumar, G. B.; Kobayashi, Y. J. Org. Chem.
2000, 65, 707.
(10) The optical rotation of the product [a]D20 +8.7 (c 1.4, CHCl3)
was in agreement with the reported value {lit.11 [a]D25 +8.3
(c 1.4, CHCl3)}.
(11) Ito, T.; Yamakawa, I.; Okamoto, S.; Kobayashi, Y.; Sato, F.
Tetrahedron Lett. 1991, 32, 371.
(12) (a) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A.
H. J. Am. Chem. Soc. 2000, 122, 8168. (b) Gessler, S.;
Randl, S.; Blechert, S. Tetrahedron Lett. 2000, 41, 9973.
(13) Preparation and Selected Data of Enone 2.
[Ru] (11 mg, 18 mmol) was added to a solution of
homoallylamine 4 (76 mg, 0.2 mmol) and enone ester 3 (60
mg, 0.4 mmol) in anhyd CH2Cl2 (4.7 mL) under a nitrogen
atmosphere. The mixture was heated at reflux for 20 h. The
solvent was evaporated and the residue was purified by
3.23–3.37 (m, 1 H, H-2), 4.21–4.36 (m, 2 H, H-15) ppm. 13
C
NMR (125 MHz, CDCl3): d = 14.1 (C-13), 21.5 (C-4), 22.7
(C-12), 24.6 (C-3), 25.2 (C-5), 32.3 (C-10, 11), 34.2 (C-9),
43.2 (C-7), 53.5 (C-14), 59.0 (C-2), 62.8 (C-6), 69.0 (C-15),
174.7 (C-8) ppm.
Synlett 2006, No. 3, 487–489 © Thieme Stuttgart · New York